baber/WOPTO huggingface dataset:
Patent EP-0711485-B1 (EP)
Inventor: BANNISTER CECIL H
IPC: H04M3/50
Filed: 1994-05-11
Granted: 1997-04-16
Abstract: L'invention se rapporte à une caractéristique de communication individuelle qui rend plus aisé le filtrage d'appels d'arrivée par l'association du numéro composé par l'appelant à une fonction ou à un rôle particulier. Cette fonction ou ce rôle est ensuite transmis à l'abonné lorsqu'un appel d'arrivée est reçu. De cette manière, l'abonné peut décider de répondre à l'appel d'arrivée en étant conscient du rôle ou du contexte associé au numéro composé. L'abonné à également accès à des caractéristiques commandées par l'utilisateur, qui peuvent être sollicitées par l'utilisation de codes de multifréquence en code 2. L'abonné peut mettre un appelant en attente avant de répondre à l'appel d'arrivée. En outre, il peut effectuer un transfert d'appel d'un téléphone sans fil à un téléphone à fil et vice-versa, tandis que l'appel est encore en cours. Une autre caractéristique permet à l'utilisateur d'exécuter un filtrage d'appel en temps réel tandis que l'appelant laisse un message sur la messagerie vocale. Encore une autre caractéristique offre un service étendu de grande portée à plusieurs abonnés de sorte qu'un appel d'arrivée sera simultanément acheminé vers chaque abonné du groupe, comme si leurs téléphones étaient des postes de lignes internes.
Patent EP-0710114-B1 (EP)
Inventor: SPIRA JACK
IPC: A61K38/43
Filed: 1994-03-31
Granted: 2003-02-26
Abstract: PCT No. PCT/SE94/00297 Sec. 371 Date Dec. 21, 1995 Sec. 102(e) Date Dec. 21, 1995 PCT Filed Mar. 31, 1994 PCT Pub. No. WO95/01804 PCT Pub. Date Jan. 19, 1995A pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration comprising recombinant coagulation factor VIII and use thereof for manufacture of a medicament for treating haemophilia is provided. The formulation comprises a highly purified recombinant coagulation factor VIII in a concentration of at least 1000 IU/ml, which gives surprisingly high levels of active factor VIII in the blood stream after subcutaneous, intramuscular or intradermal administration. The formulation is intended for treatment of haemophilia by subcutaneous, intramuscular or intradermal administration. The recombinant factor VIII is preferably a deletion derivative thereof, which can be used for the manufacture of a medicament for subcutaneous administration.
Patent EP-0706408-B1 (EP)
Inventor: RYAN TERRENCE G
IPC: A61N1/372
Filed: 1994-05-10
Granted: 1997-08-06
Abstract: Un système de télémétrie pour dispositif médical implantable permet de décoder les informations de liaison descendante de télémétrie transmises par une unité externe à un dispositif médical implanté, et de coder les signaux de liaison ascendante de télémétrie devant être transmis depuis le dispositif à l'unité externe. Une nouvelle architecture de système prévoit un sous-système de télémétrie de très petite taille dans le dispositif implantable et un système très flexible adaptable destiné à être utilisé conjointement avec divers formats de télémétrie de divers dispositifs implantés. Une structure de matrice logique programmable (PLA) programmable par masquage et partiellement programmable par RAM sert de base au sous-système de télémétrie. Pour la télémétrie de liaison descendante, un compteur est activé pendant les intervalles intéressants dans le flux de salves H.F. de liaison descendante. La valeur du compteur à la fin de ce type d'intervalle est ensuite appliquée aux entrées variables de la PLA pour le décodage à l'aide d'un protocole de télémétrie sélectionné. Pour la télémétrie de liaison ascendante, le compteur et la matrice PLA sont utilisés pour commander la transmission des impulsions de télémétrie de liaison ascendante de sorte que la position des impulsions soit modulée en fonction des données à transmettre. Différents protocoles de télémétrie programmables par masquage lors de leur fabrication de sorte qu'ils soient compatibles avec un ou plusieurs protocoles de télémétrie différents peuvent être pris en charge par le même circuit de télémétrie.
Patent EP-0671797-B1 (EP)
Inventor: MUELLER OTMAR
IPC: H02G3/08
Filed: 1995-02-28
Granted: 1998-09-09
Abstract: An electrical installation has a housing (20) with upper and lower parts and internal clips for holding electronic components and the necessary wiring. There are cable lead-ins on at least one side. Near them there is an open chamber (28), closed by a plate (31) containing the lead-in seals (35). The seals are made of soft elastic plastic, whereas the plate is made from hard plastic. The seals are grommets whose lips press against both sides of the plate. In plan view, the chamber lies below the terminal connectors (29). It can be extended by an additional cover plate. The plate is held in place by catches (32).
Patent EP-0671392-B1 (EP)
Inventor: SCHUBERT GERRIT DR
IPC: C07D471/04
Filed: 1995-03-03
Granted: 2001-02-21
Abstract: Propane derivs. of formula (I), and their salts, are new: D-B-A = opt. substd. propyl,  omega -hydroxy- (1-4C)alkyl, OH, OT, phenyl or phenyl(1-3C)alkyl); R<1> = CN, COOH (opt. protected), 1-4C alkanoyl, SO3T, SO3H, SO2NR<5>R<6>, PO(OH)2, PO(OH)(OT), PO(OT)2 or tetrazol-5-yl; R<2> = 1-10C alkyl(R<8>)n, O-(1-10C)alkyl(R<8>)n, 2-10C alkenyl(R<8>)n, O-(3-10C)alkenyl(R<8>)n, 2-10C alkynyl(R<8>)n, O-(3-10C)alkynyl(R<8>)n, S-(1-10C)alkyl(R<8>)n, etc. (all R<8> gps. being opt. substd.); R<5>, R<6> = H, T, 1-4C alkanoyl or opt. substd. phenyl; or NR<5>R<6> = a 4-10 membered, satd. heterocyclic ring (in which one CH2 gp. is opt. replaced by O, S or NR<7>); R<7> = H, T, phenyl or benzyl; X = (CH2)m, CH=CH, C  IDENTICAL C, CH2OCH2, CH2SCH2 or CH2-N(R<5>)-CH2; Y = (CH2)m, O, S or NR<5>; Z = (CH2)m, S, O, S-(1-10C)alkyl, O-(1-10C)alkyl, CH=CH, CH=CF, CH=CCl, CH=CBr, CH2CO, etc.; or when Y = O, the gp. C(O)ZR<3> may be an opt. protected amino acid residue; n = 0, 1 or 2; m = 0-4; R<3>, R<8> = 1-10C alkyl, 3-8C cycloalkyl, or opt. substd. Ar; T = 1-4C alkyl; Ar = phenyl, naphthyl, phenanthryl, pyridyl, thienyl, furyl, pyrimidyl, indolyl, etc.
Patent EP-0683996-B1 (EP)
Inventor: SCHMID GUENTER
IPC: A47B49/00
Filed: 1995-05-08
Granted: 2001-10-31
Abstract: The door is for a corner cupboard having a carousel supporting several layers of shelving. The shelves have a cut-out front segment to align with the inset corner of the cupboard. A two flange shaped door is supported on upper (25) and lower (24) slides to push inwards into the carousel and thereby free the carousel for rotation. The upper and lower mechanisms are linked by a vertical rod (28) set inside the hollow support shaft (17) of the carousel. The sliding mechanisms are sloped and the sliding action has a rack and pinion coupling with pinions on the inner rod accessed via slots in the outer support shaft. This provides a compact mounting with maximum space on the shelves.
Patent EP-0714609-B1 (EP)
Inventor: KOH HEN-SIK
IPC: A23L9/20
Filed: 1995-05-24
Granted: 2000-05-03
Abstract: The invention relates to whipping cream compositions possessing a lowered fat content and improved acid resistance and freeze resistance, and a process for producing the same. The whipping cream composition according to the present invention is composed essentially of (a) a protein, (b) an emulsifier and (c) an edible fiber and/or modified starch, the protein (a) being composed of casein protein and whey protein in a weight ratio of 0.24 to 3.8, the emulsifier (b) consisting of 0.01 to 0.5 % by weight of lecithin, 0.05 to 1.2 % by weight of a saturated fatty-acid ester of a polyglycerol and 0.02 to 0.6 % by weight of a saturated fatty-acid ester of a polyglycerol and the fiber component (c) comprising 0.05 to 5 % by weight of one or not less than two edible fiber selected from a group consisting of cellulose, hemicellulose and sparingly digestive dextrin, and/or modified starch.
Patent EP-0702927-B1 (EP)
Inventor: BAGGERMAN QUIRYN
IPC: A47L13/59
Filed: 1995-07-22
Granted: 1999-03-17
Abstract: The wiper (2) with handle has a fixing device engaging with a mating one on the bucket edge (13), and typically mounted on the handle coupling (15). It can consist of a downwards-facing hook, or two hooks at different angles on the coupling. The mating portion on the bucket edge can consist of a recess formed by beading over the bucket edge towards the outside. This works with a movable locking member on the edge and securing the hook in the recess.
Patent EP-0706753-B1 (EP)
Inventor: BEHRENS WOLFGANG
IPC: A01G1/00
Filed: 1995-09-14
Granted: 1999-10-20
Abstract: The mineral wool mat is used as a substrate for growing plants. The thickness and weight of the mat (10) are such that it can be wound into a roll ready for use in greening over a roof etc. Its thickness can be between 2 and 3.5 cm. and its weight between 30 and 80 kg/m<3>. A bottom water-permeable supporting layer (12) can be included. This is made typically of cloth or coarse meshwork and glued to the mat. A thin layer of gravel can be applied to the top surface of the mat.
Patent EP-0709904-B1 (EP)
Inventor: NANN EBERHARD DR
IPC: H01M50/536
Filed: 1995-09-29
Granted: 1998-05-06
Abstract: The part of an accumulator plate where the connection lug is to be formed is made of a plastic mesh (12). It may be metallised with Cu and Pb-Sn alloy. This part of the plate is fed between two metal strips (13,14) through a set of rollers (15,16) where the strips are forced into the plastic. Heat is applied to at least one roller in order to soften the strips but without harming the plastic mesh. The lug is then formed on the plate by cutting in a stamping machine (21).
Patent EP-0703087-B1 (EP)
Inventor: MORIYAMA JIRO
IPC: B41J2/21
Filed: 1995-08-08
Granted: 2003-05-14
Abstract: An ink jet recording apparatus comprising an ink ejection head for effecting image recording on a recording material by ejecting ink, a processing liquid ejection head for ejecting onto the recording material processing liquid effective to insolubilize the said ink, and a processing liquid ejection head for ejecting onto the recording material processing liquid effective to insolubilize the said ink, and control means for controlling ejection of the processing liquid from said processing liquid ejection head depending on a kind of the recording material in use. <IMAGE>
Patent EP-0704200-B1 (EP)
Inventor: CAUWET-MARTIN DANIELE
IPC: A61K8/00
Filed: 1995-08-21
Granted: 1997-07-23
Abstract: Cosmetic compsn. comprises a ceramide type lipid cpd. (I) and a peptide (II) with ≥ one fatty chain in an acceptable aq. medium (III). (I) is pref. N-linoleoyldihydrosphingosine, N-oleoyldihydsphingosine, N-palmitolydihydrosphingosdine, N-stearoyldihydrosphingosine and/or N-behenoyldihydrosphingosine, or bis-(N-hydroxyethyl N-cetyl)malonamide, the N-(2-hydroxyethyl)-N-(3-cetyloxy-2-hydroxypropyl)amide of cetyl acid, or N-docasanoyl N-methyl-D-glucamine present in amt. of 0.0004-10 (pref. 0.0001-5) wt.%. (II) have a mol. wt. above 1000 and contain 8-40C (10-22C) fatty chains. (II) are proteins or, pref., hydrolysates of proteins with a fatty chain present in amt. of 0.01-30 (pref. 0.1-10)%. Aq. dispersions contain 0.0001-15% (0.0001-10%) (I) and 0.01-40% (0.5-20%) of (II), with a ratio by wt. of the concn. of (II) to the concn. of (I) of 1.5-10 (pref. 2-6).
Patent EP-0727977-B1 (EP)
Inventor: BRUGGER KLAUS
IPC: F15B20/00
Filed: 1994-11-10
Granted: 1997-11-26
Abstract: PCT No. PCT/EP94/03724 Sec. 371 Date Apr. 24, 1996 Sec. 102(e) Date Apr. 24, 1996 PCT Filed Nov. 10, 1994 PCT Pub. No. WO95/13043 PCT Pub. Date May 18, 1995A hydraulic system for hydraulically actuating a vertically adjustable ambulance lifting table used for receiving thereon a stretcher and adapted to be selectively switched to a cushioned mode of operation comprises a cylinder for actuating the lifting table, a hydraulic accumulator for cushioning the lifting table, a pump, a three-way valve, and a discharge valve connected to a reservoir of the hydraulic system on the outlet side thereof. In order to prevent the patient and/or the medical personnel from being exposed to danger by the lifting table when the above-mentioned hydraulic system is used, and even if the hydraulic system is actuated incorrectly, the three-way valve is in fluid connection with the pump and the hydraulic accumulator on the inlet side thereof and with the cylinder on the outlet side thereof, a valves is provided between the cylinder on the one hand and the hydraulic accumulator on the other, the valves is controlled such that it assumes an open position only if the pressure in the hydraulic accumulator exceeds the pressure within the cylinder by not more than a predetermined pressure difference, and the input side of the discharge valve is in fluid connection either with the hydraulic accumulator or with the cylinder depending on the pressure prevailing in the hydraulic accumulator relative to the pressure prevailing in the cylinder.
Patent EP-0735844-B1 (EP)
Title: Dispositif destine a etre place dans une ouverture pratiquee dans la trachee
Inventor: PERSSON JAN-OVE
IPC: A61M16/10
Filed: 1994-12-21
Granted: 1997-09-10
Abstract: Dispositif conçu pour être placé dans une ouverture pratiquée dans la trachée et composé d'un boîtier de filtre (10) servant à loger un filtre d'humidité et d'échange thermique (11), ledit boîtier possédant une première ouverture (12) destinée à l'ouverture dans la trachée du patient, et au moins une deuxième ouverture (14) au niveau du côté opposé du filtre (11). D'après l'invention, un clapet servant à fermer ladite deuxième ouverture (14) du boîtier de filtre (10) et conçu pour être fermé manuellement au moyen d'un doigt et ouvert par retour d'élastique, est situé au niveau de ladite deuxième ouverture.
Patent EP-0738332-B1 (EP)
Inventor: OLIVO PAUL D
IPC: C12Q1/6897
Filed: 1994-12-20
Granted: 2001-10-24
Abstract: Cell lines and methods are disclosed for detecting the presence of RNA viruses in a specimen. The cell lines are stably transformed with a DNA molecule that includes a promoter capable of being recognized by the DNA dependent RNA polymerase of the cell capable of directing the transcription of a cDNA of a structurally defective RNA virus genome operably coupled to the promoter. The cDNA contains a structural coding sequence encoding a selected reporter gene product. The RNA molecules transcribed by the DNA dependent RNA polymerase are not capable of causing the translation of the reporter gene in the cell except when an active related virus that provides the necessary trans-acting enzymes to cause the increased replication of the RNA containing the reporter gene which is then translated into the reporter gene product is provided. Methods utilizing the cell lines of this invention to detect RNA viruses in a specimen by incubating the specimen with the cell line and assaying for expression of the reporter gene and a kit containing a supply of the cells and a supply of the reagents necessary for the detection of the reporter gene product are also provided.
Patent EP-0744950-B1 (EP)
Inventor: IKEGAWA RURIKO
IPC: A61P9/00
Filed: 1995-02-20
Granted: 2004-08-18
Abstract: PCT No. PCT/JP95/00244 Sec. 371 Date Aug. 8, 1996 Sec. 102(e) Date Aug. 8, 1996 PCT Filed Feb. 20, 1995 PCT Pub. No. WO95/22329 PCT Pub. Date Aug. 24, 1995An agent for the prophylaxis or treatment of TXA2-mediated diseases, particularly, a TXA2 synthetase inhibitor, which comprises a pyridazinone compound of the formula (I)    <IMAGE>  (I)  wherein each symbol is as defined in the specification, or a pharmacologically acceptable salt thereof as an active ingredient. The pyridazinone compound (I) and pharmacologically acceptable salts thereof used in the present invention have prophylactic and therapeutic activities against TXA2-mediated diseases, particularly a TXA2 synthetase inhibitory action and are useful as an agent for the prophylaxis or treatment of TXA2-mediated diseases, particularly as TXA2 synthetase inhibitors.
Patent EP-0744987-B1 (EP)
Inventor: RONNING SVEIN O
IPC: C01B32/50
Filed: 1995-02-14
Granted: 1998-06-17
Abstract: PCT No. PCT/NO95/00033 Sec. 371 Date Oct. 11, 1996 Sec. 102(e) Date Oct. 11, 1996 PCT Filed Feb. 14, 1995 PCT Pub. No. WO95/21683 PCT Pub. Date Aug. 17, 1995A method for removing and preventing emissions into the atmosphere of carbon dioxide (CO2) from exhaust gases from gas turbines for the production of oil and gas, comprising the following steps: (a) natural gas and air are introduced into a gas turbine in which natural gas is converted to mechanical energy; (b) the exhaust gas from the gas turbine is passed through a heat recovery unit for recovery of the heat content in the exhaust gas; (c) after emitting heat in the recovery unit whereby the temperature of the exhaust gas has been reduced to 20 DEG -70 DEG  C., the exhaust gas is passed to an absorption column containing an absorption liquid, where the carbon dioxide is absorbed in the said liquid, and the thereby purified exhaust gas, essentially free of carbon dioxide, is vented to the atmosphere; (d) the absorption liquid which contains CO2 is passed to a stripping column where the CO2 is removed from the absorption liquid heated to a temperature of 120 DEG -150 DEG  C.; (e) the thereby regenerated absorption liquid which is essentially free of CO2 is recycled to the absorption column and the separated CO2 gas is passed to a compression stage for compression and utilization or disposal; wherein approximately 40% of the exhaust gas is recycled to the compressor air inlet for said gas turbine before the exhaust gas is passed to the absorption stage (c).
Patent EP-0748527-B1 (EP)
Title: Connecteur de bords d'une carte a circuits imprimes assurant des connexions electriques non simultanees
Inventor: THRUSH ROGER LEE
IPC: H01R12/83
Filed: 1995-02-07
Granted: 1997-10-01
Abstract: Un connecteur conçu pour établir une connexion électrique avec une carte de circuit comprend un boîtier diélectrique (10) présentant une fente (14) de réception de la carte et une pluralité de bornes (30) disposées de façon à venir se placer contre les contacts respectifs (41-43) de la carte (4) du circuit. Les bornes sont agencées sous forme d'au moins des premier et second ensembles (41, 43) correspondants au premier et second groupes respectifs de contacts sur la carte du circuit. Le premier ensemble (30a) de bornes vient en contact avec le premier groupe (41) de contacts lorsque la carte (4) du circuit est insérée dans la fente (14) dans une première position, et le second ensemble (30c) de bornes vient en contact avec le second groupe (43) de contacts lorsque la carte du circuit pivote dans un angle vers une seconde position. Lorsqu'on retire la carte du circuit du connecteur, les bornes du second ensemble (30c) sont dégagées de leurs contacts respectifs avant les bornes du premier ensemble (30a). On obtient ainsi un connecteur qui possède des bornes disposées de façon à ce qu'une partie de celles-ci assure des interconnexions électriques d'abord avec chevauchement, ensuite sans chevauchement.
Patent EP-0804622-B1 (EP)
Inventor: AXELSSON CARL-LENNART
IPC: C21D1/76
Filed: 1995-03-07
Granted: 1999-06-02
Abstract: PCT No. PCT/SE95/00243 Sec. 371 Date Sep. 6, 1996 Sec. 102(e) Date Sep. 6, 1996 PCT Filed Mar. 7, 1995 PCT Pub. No. WO95/24509 PCT Pub. Date Sep. 14, 1995A method for heat-treating steel, primarily strip-like or rod-like steel material, such as steel strip, steel sheet, steel rod or steel wire which have been rolled and heated in an oven or furnace to a surface temperature above about 900 degrees C. and thereafter cooled and optionally treated in an electrolyte bath and/or acid bath. The oven burners are fired with a liquid or a gaseous fuel which is burned with the aid of a gas that contains at least 85 percent by volume oxygen and at most 10 percent by volume nitrogen.
Patent EP-0712367-B1 (EP)
Inventor: SUTHERLAND ROBERT L
IPC: B65D71/12
Filed: 1995-02-27
Granted: 1999-04-21
Abstract: A carrier especially suited for carrying beverage cans. The carrier is comprised of a top panel connected to support panels which contain slots for receiving the can chimes. In addition, short side panel flaps connected to the support panels and end panel flaps connected to the top panel assist in holding the cans in place. Webs foldably connected to the side panel flaps and to extensions of the end panel flaps cause the end panel flaps to be automatically drawn into place. The side panel flaps, the webs and the end panel extensions are glued together to hold the carrier in locked condition.
Patent EP-0749566-B1 (EP)
Inventor: LARSSON KAJ
IPC: G01J3/45
Filed: 1995-03-09
Granted: 1999-10-06
Abstract: An interferometer includes a beam splitter (BS) and two scanning mirrors (M1, M2), which are parallel and disposed on a common slide member that can be linearly displaced. The interferometer further comprises two compensating mirrors (M3, M4), which are disposed between the beam splitter (BS) and the scanning mirrors (M1, M2). The beam splitter (BS) and each of the compensating mirrors (M3, M4) are orthogonal. The interferometer has good tolerance for displacement inaccuracies of the scanning mirrors (M1, M2). The interferometer may be used for producing a compact and inexpensive Fourier transform spectrometer.
Patent EP-0758254-B1 (EP)
Inventor: SOHN ZEV
IPC: A61M60/126
Filed: 1995-05-02
Granted: 2008-01-23
Abstract: Medical apparatus includes an external drive magnet mounted for rotation externally of a subject's body, an implantable driven magnet configured and dimensioned to be implantable in the subject's body and mounted for rotation by magnetic coupling with the drive magnet and an implantable device mechanically coupled to the driven magnet to be driven thereby. The driven magnet is mountable for rotation in the subject's body about an axis of rotation which is not collinear with the axis of rotation of the external drive magnet such that the magnetic poles of the external drive magnet are magnetically coupled sequentially with the magnetic poles of the implanted driven magnet to rotate the implanted driven magnet, thereby providing flexibility in the location, design and dimensions of the implanted driven magnet, and in the speed and torque ratios between the two magnets.
Patent EP-0759693-B1 (EP)
Inventor: WEINER DAVID B
IPC: C07K16/10
Filed: 1995-05-17
Granted: 2003-11-26
Abstract: A method for treating an individual exposed to or infected with HIV is disclosed which comprises administering to said individual a therapeutically effective amount of one or more compounds which inhibit or prevent replication of said HIV by interfering with the replicative or other essential functions of Vpr expressed by said HIV, by interactively blocking the Vpr target in human cells, and thereby preventing translocation of the Vpr/target complex from the cytosol of said human cells to the nuclei of said cells, where Vpr carries on activities essential to replication of HIV. In preferred embodiments, the compound or compounds which interactively block the target are steroid hormone receptor antagonists, glucocorticoid receptor antagonists, or glucocorticoid receptor Type II antagonists, especially mifepristone (RU-486). Pharmaceutical compositions comprising these compounds, as well as a method for identifying them and a kit for use therein, are also disclosed.